Herein, we describe the first synthesis of anionic silaketenimines
and the coupling product with an isocyanide. Treatment of boryl silanorcaradienyllithium
[CH2(L)N]2BSiLi (where L = B[N(Ar)CH]2 and Ar = 2,6-iPr2C6H3) with isocyanides afforded silaketenimine anions [CH2(R)N]2BSi(Li)CNR featuring a SiCN
allenic structure. X-ray diffraction studies and density functional
theory calculations strongly support the presence of an anionic silicon
atom and a strong π bond between the silicon and carbon atoms.
One of the silaketenimine anions underwent a formal [2 + 2] cycloaddition
reaction with a second molecule of isocyanide to give a novel silacyclopropyl
anion with a delocalized anionic skeleton. These reactions
demonstrated that the bonding nature of the boryl lithiosilylene was
distinct from that of common silylenes.
Herein we report
the first synthesis of a 1-magnesium-2,3-disilacyclopropene
and a related bis(disilenide). Reduction of (boryl)tribromosilane
(1, boryl = (HCArN)2B, Ar = 2,6-iPr2C6H3) with magnesium in THF afforded
boryl-substituted magnesium complex [(boryl)Si]2Mg(THF)3 (2) in good yield, whereas reduction of (boryl)trichlorosilane
(3) with KC8 in THF led to the isolation of
bridged alkoxy alkyl bis(disilenide) (THF)K(boryl)SiSi(boryl)O(CH2)4(boryl)SiSi(boryl)K(THF) (4) via ring opening of a THF molecule. X-ray diffraction analysis
of 2 confirmed the presence of the novel Si2Mg three-membered ring as well as the SiSi double bond, which
existed in a noticeably twisted B–Si–Si–B array.
Complex 2 also represents the first reported example
of a stable disilyne dianion.
Reduction of (boryl)dibromosilane (boryl)SiHBr 2 (1; boryl = B(NArCH) 2 , Ar = 2,6-iPr 2 C 6 H 3 ) with 2 equiv of potassium graphite in DME at low temperature led to the isolation of bis(boryl)disilane (boryl)SiH 2 SiH 2 (boryl) (3) as a colorless solid, whereas reduction of (boryl)SiPhBr 2 (2) in THF gave the boryl-substituted disilene (boryl)-PhSiSiPh(boryl) (4) as a yellow solid. The reaction of 1 with 1,3diisopropyl-4,5-dimethylimidazol-2-ylidene (IiPr) unexpectedly led to the formation of the cationic species [(boryl)SiHBr(IiPr)] + Br − (6). These products were characterized by spectroscopic methods as well as by X-ray single-crystal analysis.
A series of novel
bis-BN-naphthalene-fused oxepin derivatives were
synthesized via a Pd-catalyzed tandem reaction from brominated 2,1-borazaronaphthalenes
and cis-bis(boryl)alkenes. X-ray crystallographic analysis revealed
that bis-BN-naphthalene-fused oxepins feature a planar framework.
The electronic and photophysical properties of the novel BN-naphthalene-fused
oxepins were investigated by UV–vis and fluorescence spectroscopies
and density functional theory (DFT) calculations, which disclosed
the distinct electronic and photophysical properties of the analogous
hydrocarbon system. Interestingly, dual-fluorescent emissions were
observed upon dissolving N-substituted derivatives 10–14 in dimethyl sulfoxide. Tunable emission colors
especially for white-light emissions can be achieved by controlling
the ratio of solvents, concentration, or temperature using only a
single-molecule compound.
The first examples of cyclic (alkyl)(amino)carbene
(CAAC) lanthanide
(Ln) complexes were synthesized from the reaction of CAAC with Yb[N(SiMe3)2]2 and Eu[N(SiMe3)2]2(THF)2 (THF = tetrahydrofuran). The
structures of (CAAC)Yb[N(SiMe3)2]2 (2) and (CAAC)Eu[N(SiMe3)2]2(THF) (3) were determined by X-ray diffraction
analysis. Density functional theory calculations of 2 revealed the predominantly ionic bond between the Ln ion and CAAC.
Complex 3 enabled catalytic hydrosilylation of aryl-
and silylalkenes with primary and secondary silanes in high yields
and Markovnikov selectivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.